Michael Krel
Partner at Sofinnova Partners | Greater Paris Metropolitan Region, France
Michael Krel’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Member of the Board at EnobraQ in February 2017 - Present
Board observer at Comet Bio in March 2016 - Present
Board member at AFYREN in February 2019 - Present
Board Member at Enginzyme in March 2020 - Present
Partner at Sofinnova Partners in January 2020 - Present
Board Member at Werewool in April 2023 - Present
Board Member at ELICIT PLANT in September 2021 - Present
Board Member at Meiogenix in July 2021 - Present
Board Member at Microphyt in June 2022 - Present
Principal at Sofinnova Partners in February 2017 - January 2020
senior associate at Sofinnova Partners in March 2013 - February 2017
CEO at EnobraQ in November 2015 - February 2017
VP Business Development at Deinove in December 2010 - February 2013
business development manager at Metabolic explorer in November 2007 - December 2010
consultant at Arendi Consulting in January 2005 - January 2007
doctorant/ cadre de laboratoire at ICNS CNRS in February 2002 - June 2005
École Polytechnique, PhD, January 2002 to January 2005
ICSN, PhD, January 2002 to January 2005
ICSN, Doctor of Philosophy (Ph.D.), January 2002 to January 2005
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future. Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €4 billion under management. For more information, please visit: www.sofinnovapartners.com
Discover more about Sofinnova Partners
Partner Sofinnova Telethon Fund
Partner Sofinnova Telethon Fund at Sofinnova Partners
(October 2018 – Present)
Managing Partner at Sofinnova Partners
Board Member at Asceneuron SA
(September 2015 – Present)
Partner at Sofinnova Partners
Board Member at Excelsior Sciences
(Aug 2025 – Present)
Life Science Investor at Sofinnova Partners
Partner at Sofinnova Partners
(Sep 2024 – Present)
Partner at Sofinnova Partners
Partner at Sofinnova Partners
(May 2024 – Present)
AI Product Engineer & Data Scientist | PhD in Computational Neuroscience
Sofinnova Partners is one of the largest biotech venture firms in Europe (€4bn AUM).
Working on Sofinnova.AI, a proprietary AI platform to augment life sciences investing.
What is Michael Krel email address?
Email Michael Krel at [email protected] and [email protected]. This email is the most updated Michael Krel's email found in 2026.
How to contact Michael Krel?
To contact Michael Krel send an email to [email protected] or [email protected].
What company does Michael Krel work for?
Michael Krel works for Sofinnova Partners.
What is Michael Krel's role at Sofinnova Partners?
Michael Krel is Partner
What industry does Michael Krel work in?
Michael Krel works in the Venture Capital & Private Equity industry.
